Nuffield Council on Bioethics welcomes the Chief Medical Officer's Report on Stem Cell Research
Wed, 16 August 2000
PRESS RELEASE
Nuffield Council on Bioethics welcomes the Chief Medical Officer's Report on Stem Cell Research
Today the Nuffield Council on Bioethics welcomed the findings of the Chief Medical Officer's Expert Group which reported on stem cell research. In April 2000 the Council published a discussion paper entitled 'Stem cell therapy: the ethical issues' and concluded that research into human stem cells had the potential to develop treatments for a variety of diseases and should be permitted with safeguards. The report of the CMO's group drew similar conclusions and proposed measures to implement such safeguards.
"We were very pleased to see that the CMO's Report addressed important ethical issues such as the need for specific consent by embryo donors to embryonic stem cell research" said Dr Sandy Thomas, director of the Nuffield Council on Bioethics.
Research on the transfer of a nucleus from a somatic cell, with the aim of producing stem cells for cell and tissue therapy, has raised concerns that these developments will increase the likelihood of reproductive cloning. Such a procedure is not permissible under UK law and the Council welcomes the Government commitment to put legislation in place to set out unequivocally the ban on reproductive cloning.
END
For further information contact:
Yvonne Melia, Nuffield Council on Bioethics, 28 Bedford Square, London WC1B 3JS
Tel: 020 7681 9625, Fax: 020 7637 1712. Email: ymelia@nuffieldfoundation.org
Notes to Editors
The Nuffield Council on Bioethics is an independent body, which examines the ethical issues raised by developments in medicine and biology. Established in 1991, it is funded by the Nuffield Foundation, the Medical Research Council and the Wellcome Trust. Further information may be obtained from the Nuffield Council's website. The Council's discussion paper is available on its website at http://www.nuffieldfoundation.org/bioethics/
Last Updated Thu, 24 June 2004